Luis San

4.0k total citations
103 papers, 2.8k citations indexed

About

Luis San is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Luis San has authored 103 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Psychiatry and Mental health, 27 papers in Clinical Psychology and 13 papers in Pharmacology. Recurrent topics in Luis San's work include Schizophrenia research and treatment (37 papers), Bipolar Disorder and Treatment (17 papers) and Healthcare Decision-Making and Restraints (12 papers). Luis San is often cited by papers focused on Schizophrenia research and treatment (37 papers), Bipolar Disorder and Treatment (17 papers) and Healthcare Decision-Making and Restraints (12 papers). Luis San collaborates with scholars based in Spain, United Kingdom and United States. Luis San's co-authors include Belén Arranz, Gavin P. Reynolds, Lucy A. Templeman, Jordi Camı́, Antonio Ciudad, Inmaculada Gilaberte, Enric Álvarez, Marta Torrens, Pilar Rosel and Julio Bobes and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Clinical Chemistry.

In The Last Decade

Luis San

98 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis San Spain 29 1.4k 882 379 341 283 103 2.8k
G. William MacEwan Canada 22 1.4k 1.0× 501 0.6× 513 1.4× 369 1.1× 129 0.5× 82 2.7k
Winston W. Shen Taiwan 30 1.2k 0.9× 478 0.5× 270 0.7× 406 1.2× 237 0.8× 110 3.1k
John Lally United Kingdom 27 2.0k 1.5× 607 0.7× 185 0.5× 232 0.7× 201 0.7× 99 3.4k
George W. Arana United States 30 1.2k 0.9× 1.1k 1.3× 290 0.8× 484 1.4× 155 0.5× 76 3.7k
H.‐J. Möller Germany 36 2.4k 1.8× 689 0.8× 399 1.1× 660 1.9× 124 0.4× 140 4.2k
Rachel Upthegrove United Kingdom 30 2.1k 1.5× 1.1k 1.2× 203 0.5× 273 0.8× 150 0.5× 142 4.2k
Ric M. Procyshyn Canada 33 1.6k 1.2× 396 0.4× 485 1.3× 392 1.1× 124 0.4× 143 3.2k
J.C. Ballenger United States 19 846 0.6× 809 0.9× 441 1.2× 374 1.1× 156 0.6× 196 2.2k
Manit Srisurapanont Thailand 30 1.4k 1.0× 677 0.8× 833 2.2× 708 2.1× 325 1.1× 126 3.6k
Donna A. Wirshing United States 28 2.4k 1.7× 653 0.7× 262 0.7× 379 1.1× 210 0.7× 50 3.4k

Countries citing papers authored by Luis San

Since Specialization
Citations

This map shows the geographic impact of Luis San's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis San with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis San more than expected).

Fields of papers citing papers by Luis San

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis San. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis San. The network helps show where Luis San may publish in the future.

Co-authorship network of co-authors of Luis San

This figure shows the co-authorship network connecting the top 25 collaborators of Luis San. A scholar is included among the top collaborators of Luis San based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis San. Luis San is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arranz, Belén, Marina Garriga, Clemente García‐Rizo, & Luis San. (2017). Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review. European Neuropsychopharmacology. 28(2). 227–242. 21 indexed citations
2.
San, Luis, et al.. (2016). State of Acute Agitation at Psychiatric Emergencies in Europe: The STAGE Study. Clinical Practice and Epidemiology in Mental Health. 12(1). 75–86. 36 indexed citations
3.
San, Luis, Belén Arranz, Víctor Pérez, et al.. (2012). One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis. Psychiatry Research. 200(2-3). 693–701. 26 indexed citations
4.
San, Luis, et al.. (2011). Immediate clinical assessment of medical intervention in schizophrenic patients admitted to an acute-care psychiatric unit: A retrospective, naturalistic and multicenter study. International Journal of Psychiatry in Clinical Practice. 15(3). 196–203. 2 indexed citations
5.
Ciudad, Antonio, Luis San, Miquel Bernardo, et al.. (2011). Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 36(2). 245–250. 17 indexed citations
6.
Ciudad, Antonio, Enric Álvarez, Julio Bobes, et al.. (2009). Remission in schizophrenia: Results from a 1-year follow-up observational study. Schizophrenia Research. 108(1-3). 214–222. 49 indexed citations
7.
San, Luis, Marta Casillas, Antonio Ciudad, & Inmaculada Gilaberte. (2008). Olanzapine Orally Disintegrating Tablet: A Review of Efficacy and Compliance. CNS Neuroscience & Therapeutics. 14(3). 203–214. 33 indexed citations
8.
San, Luis, Belén Arranz, & José Martı́nez-Raga. (2007). Antipsychotic Drug Treatment of Schizophrenic Patients with Substance Abuse Disorders. European Addiction Research. 13(4). 230–243. 24 indexed citations
9.
Arranz, Belén, Pilar Rosel, Luis San, et al.. (2007). Low baseline serotonin-2A receptors predict clinical response to olanzapine in first-episode schizophrenia patients. Psychiatry Research. 153(2). 103–109. 10 indexed citations
10.
Templeman, Lucy A., Gavin P. Reynolds, Belén Arranz, & Luis San. (2005). Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenetics and Genomics. 15(4). 195–200. 215 indexed citations
11.
San, Luis. (2005). Evolución de la dependencia de heroína y su asistencia en España. Adicciones. 17(2). 9–19.
12.
Keith, Samuel J., Luca Pani, Robin Emsley, et al.. (2004). Practical Application of Pharmacotherapy With Long-Acting Risperidone for Patients With Schizophrenia. Psychiatric Services. 55(9). 997–1005. 59 indexed citations
13.
14.
Arranz, Belén & Luis San. (2001). Aproximación terapeútica de la dependencia de cocaína. Adicciones. 13. 191–208. 5 indexed citations
15.
Wright, Pádraig, Martin Birkett, S.R. David, et al.. (2001). Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia. American Journal of Psychiatry. 158(7). 1149–1151. 218 indexed citations
16.
Rosel, Pilar, Belén Arranz, Luis San, et al.. (2000). Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicide victims. Psychiatry Research Neuroimaging. 99(3). 173–181. 62 indexed citations
17.
San, Luis, Marta Torrens, Claudio Castillo, Miquel Porta, & Rafael de la Torre. (1993). Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross–sectional studies in 1988 and 1990. Addiction. 88(10). 1341–1349. 37 indexed citations
18.
Camı́, Jordi, et al.. (1992). Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. British Journal of Addiction. 87(8). 1145–1151. 44 indexed citations
19.
San, Luis, et al.. (1990). Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial. British Journal of Addiction. 85(1). 141–147. 46 indexed citations
20.
García-Alonso, Fernando, et al.. (1989). A multicentre study to introduce naltrexone for opiate dependence in Spain☆. Drug and Alcohol Dependence. 23(2). 117–121. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. William MacEwan Breakdown of academic impact, for papers by Winston W. Shen Breakdown of academic impact, for papers by John Lally Breakdown of academic impact, for papers by George W. Arana Breakdown of academic impact, for papers by H.‐J. Möller Breakdown of academic impact, for papers by Rachel Upthegrove Breakdown of academic impact, for papers by Ric M. Procyshyn Breakdown of academic impact, for papers by J.C. Ballenger Breakdown of academic impact, for papers by Manit Srisurapanont Breakdown of academic impact, for papers by Donna A. Wirshing
Rankless by CCL
2026